Advances in Magnetofection & − Magnetically Guided Nucleic Acid Delievery:a Review
Home >
2013,
Vol. 1 No. 1 > Advances in Magnetofection & − Magnetically Guided Nucleic Acid Delievery:a Review
Authors
- Sandeep AroraChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Girish GuptaOmni Active Health Technologies, Thane, Maharashtra, INDIA
- Sukhbir SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Neelam SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
Keywords
Magnetofection, Magnetic Nanoparticles, Nucleic Acid Therapy, Magnetic Drug Targeting
Abstract
During the last decade, nanomagnetic methods for delivering and targeting nucleic acids have been developed which are often referred to as magnetofection. Nucleic acids carry the building plans of living systems. As such, they can be exploited to make cells produce a desired protein, or to shut down the expression of endogenous genes or even to repair defective genes. Hence, nucleic acids are unique substances for research and therapy. To exploit their potential, they need to be delivered into cells which can be a challenging task in many respects. Magnetofection provides a novel tool for high throughput gene screening in vitro and can help to overcome fundamental limitations to gene therapy in vivo. Magnetofection is nucleic acid delivery to cells, supported and site-specifically guided by the attractive forces of magnetic fields acting on nucleic acid shuttles (vectors) which are associated with magnetic nanoparticles. In a magnetofection procedure, self-assembling complexes of enhancers like cationic lipids with plasmid DNA or small interfering RNA (siRNA) are associated with magnetic nanoparticles and are then concentrated at the surface of cultured cells by applying a permanent inhomogeneous magnetic field.
References
- Boussif, O. (1995) ‘A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo – Polyethylenimine’. Proceedings of the National Academy of Sciences of the United State of America, Vol 92, pp. 7297–7301 http://dx.doi.org/10.1073/pnas.92.16.7297
- Campbell, K. Calvo, C. J. Mironov, S. Herron, T. Berenfeld, O and Jalife, J. (2012) ‘Spatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayers’. J Physiol., Vol 590, 24, pp. 6363-6379 http://dx.doi.org/10.1113/jphysiol.2012.238758
- Cotton, M. (1994) ‘Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid’. Virology, Vol 205, pp. 254–261 http://dx.doi.org/10.1006/viro.1994.1641
- Curiel, D.T. (1999) ‘Strategies to adapt adenoviral vectors for targeted delivery’. Annals of New York Academy of Sciences, Vol 886, pp.158–171 http://dx.doi.org/10.1111/j.1749-6632.1999.tb09409.x
- Fasbender, A. (1998) ‘Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo’. J Clin Invest, Vol 102, pp. 184–193. http://dx.doi.org/10.1172/JCI2732
- Finsinger, D. (2000) ‘Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery’. Gene Therapy, Vol 7, pp.1183–1192. http://dx.doi.org/10.1038/sj.gt.3301227
- Fouriki, A. Farrow, N. Clements, M.A. and Dobson, J. (2010) ‘Evaluation of the magnetic field requirements for nanomagnetic gene transfection’. Nano Reviews, Vol 1, 10, pp. 1-5
- Hiemenz, P.C. (1986) ‘Principles of Colloid and Surface Chemistry’ (2nd ed.) Marcel Dekker: NewYork, pp. 508-528
- Hughes, C. Galea-Lauri, J. Farzaneh, F. and Darling, D. (2001) ‘Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors’. Mol Therapy, Vol 3, pp. 623–630. http://dx.doi.org/10.1006/mthe.2001.0268
- Isner, J.M. (1996) ‘Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease’. Human Gene Therapy, Vol 20, pp. 959–988 http://dx.doi.org/10.1089/hum.1996.7.8-959
- Kanof, M.E. Smith, P.D. and Zola, H. (1999) ‘Preparation of human mononuclear cell populations and subpopulations, In: Coligan JE’. Current Protocols in Immunology. John Wiley: New York, pp. 7
- Kasahara, N. Dozy, A.M. and Kan, Y.W. (1994) ‘Tissue-specific targeting of retroviral vectors through ligand-receptor interactions’. Science, Vol 266, 5189, pp. 1373–1376 http://dx.doi.org/10.1126/science.7973726
- Kru¨ger, A. Schirrmacher, V. and Von, H.P. (1994) ‘Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells’. International J Cancer, Vol 58, pp. 275–284 http://dx.doi.org/10.1002/ijc.2910580222
- Leon, R.P. (1998) ‘Adenoviral-mediated gene transfer in lymphocytes’. Proceedings of the National Academy of Sciences of the United State of America, Vol 95, pp. 13159– http://dx.doi.org/10.1073/pnas.95.22.13159
- Leventis, R. and Silvius, J.R. (1990) ‘Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles’. Biochimica et biophysica acta, Vol 1023, pp. 124–132 http://dx.doi.org/10.1016/0005-2736(90)90017-I
- Li, D. Duan, L. Freimuth, P. O’Malley and Jr, B.W. (1999) ‘Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer’. Clinical Cancer Research, Vol 5, pp. 4175–4181
- Lu¨bbe, A.S. (1996) ‘Clinical experiences with magnetic drug targeting: a phase I study with 4-epidoxorubicin in 14 patients with advanced solid tumors.’ Cancer Research;
- Vol. 56, pp. 4686–4693
- Lu¨bbe, A.S. and Bergemann, C. (1998) ‘Magnetically controlled drug targeting’ The Cancer J, Vol 1, pp. 104–105
- Luo, D. Saltzman, W.M. (2000) ‘Enhancement of transfection by physical concentration of DNA at the cell surface’. Nature Biotechnology, Vol 18, pp. 893–895
- http://dx.doi.org/10.1038/78523
- Ma, Y. Zhang, Z. Wang, X. Xia, W and Gu, H. (2011) ‘Insights into the mechanism of magnetofection using MNPs-PEI/pDNA/free PEI magnetofectins’. Intnl J Pharmaceutics. Vol 31, 419,
- pp. 247-54 http://dx.doi.org/10.1016/j.ijpharm.2011.07.017
- Mair, L. (2009) ‘Size-Uniform 200 nm Particles: Fabrication and Application to Magnetofection’. J Biomed Nanotechnology, Vol 5, 10, pp. 182–191
- http://dx.doi.org/10.1166/jbn.2009.1024
- Mendenhall, G.D. Geng, Y. and Hwang, J. (1996) ‘Optimization of long-term stability of magnetic fluids from magnetite and synthetic polyelectrolytes’. J Colloid Interface
- Sciences, Vol 184, pp. 519–526 http://dx.doi.org/10.1006/jcis.1996.0647
- Meyer, K.B. (1995) ‘Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics’. Gene Therapy, Vol 2, pp. 450–460
- Mykhaylyk, O. Zelphati, O. Rosenecker, J. and Plank, C. (2008) ‘siRNA delivery by magnetofection’ Current Opinion of Molecular Therapy, Vol 10, 5, pp. 493-505
- Pickles, R.J. (2000) ‘Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to
- adenovirus-mediated gene transfer’. J Virology, Vol 74, pp. 6050–6057. http://dx.doi.org/10.1128/JVI.74.13.6050-6057.2000
- Plank, C. (1994) ‘The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems’. J Biological Chem, Vol 269, pp. 12918–
- Plank, C. Anton, M. Rudolph, C. Rosenecker, J. and Krötz, F. (2003) ‘Enhancing and targeting nucleic acid delivery by magnetic force’. Expert opinion on biological therapy,
- Vol 3, 5, pp.745–758. http://dx.doi.org/10.1517/14712598.3.5.745
- Plank, C. Schillinger, U. and Scherer, F. (2003) ‘The magnetofection method: using magnetic force to enhance gene delivery’. J Biol Chem, Vol 384, 5, pp. 737–747
- Plank, C. Tang, M. Wolfe, A. and Szoka, F.C. (1999) ‘Branched cationic peptides for gene delivery. Role of type and number of cationic residues in formation and in vitro
- activity of DNA polyplexes’. Human Gene Therapy, Vol 10, pp. 319–333 http://dx.doi.org/10.1089/10430349950019101
- Plank, C. Zelphati, O and Mykhaylyk, O. (2011) ‘Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects’. Advanced Drug Delivery Reviews. Vol 63, 14, pp. 1300-1331 http://dx.doi.org/10.1016/j.addr.2011.08.002
- Povey, A.C. Bartsch, H. Nixon, J.R. and O’Neill, I.K. (1986) ‘Trapping of chemical carcinogens with magnetic polyethyleneimine microcapsules: I. Microcapsule preparation
- and in vitro reactivity of encapsulated nucleophiles’. J Pharm Sci, Vol 75, pp. 831–837. http://dx.doi.org/10.1002/jps.2600750902
- Scherer, F. Anton, M. and Schillinger, U. (2002). ‘Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo’. Gene Therapy, Vol 9, 2, pp. 102–109. http://dx.doi.org/10.1038/sj.gt.3301624
- Schillinger, U. Brill, T. Rudolph, C. Huth, S. Gersting, S. and Krötz, F. (2005) ‘Advances in magnetofection – magnetically guided nucleic acid delivery’ J Magnetism and Magnetic Material. Vol 293, pp. 501–508 http://dx.doi.org/10.1016/j.jmmm.2005.01.032
- Shayakhmetov, D.M. Papayannopoulou, T. Stamatoyannopoulos, G. and Lieber, A. (2000) ‘Efficient gene transfer into human CD34 (+) cells by a retargeted adenovirus vector’. J Virology, Vol 74, pp. 2567–2583 http://dx.doi.org/10.1128/JVI.74.6.2567-2583.2000
- Sukoyan, M. A. Khrapov, E. A. Voronina, E. N. Boyarskikh, U. A. Gubanov, A. I. Itin, V. I. Magaeva, A. A. Nayden, E. P. Terekhova, O. G and Filipenko, M. L. (2013) ‘Magnetofection of Human Somatic Cells with Magnetite and Cobalt Ferrospinel Nanoparticles’. Bulletin of Exp Biol and Med. Vol 154, 5, pp. 673-676 http://dx.doi.org/10.1007/s10517-013-2027-2
- Tomko, R.P. Xu, R. and Philipson, L. (1997) ‘HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses’. Proceedings of the National Academy of Sciences of the United State of America, Vol 94, pp. 3352–3354. http://dx.doi.org/10.1073/pnas.94.7.3352
- Widder, K.J. (1983) ‘Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition’. European J Cancer Clinical Oncology, Vol 19, pp.141–147 http://dx.doi.org/10.1016/0277-5379(83)90409-1
- Wu, G.Y. and Wu, C.H. (1987) ‘Receptor-mediated in vitro gene transformation by a soluble DNA carrier system’. The J Biol Chem, Vol 262, pp.4429–4432
- http://www.bocascientific.com/transfectionmagnetofection-c-141.html>
- http://www.chemicell.com/products/Magnetofection/Magnetofection_separation.html>
- http://www.ozbiosciences.com/magnetofection.html>
How to Cite
Sandeep Arora, Girish Gupta, Sukhbir Singh, Neelam Singh. Advances in Magnetofection & − Magnetically Guided Nucleic Acid Delievery:a Review.
J. Pharm. Technol. Res. Manag.. 2013, 01, 19-29
